DXCM

Dexcom Inc. develops and markets continuous glucose monitoring (CGM) systems that provide real‑time glucose data to people with diabetes, primarily through wearable sensors and mobile applications. The company operates within the medical‑device and health‑technology sector, focusing on diabetes management solutions. Dexcom is a leading player in the CGM market, holding a significant share of the U.S. and international markets and maintaining a portfolio of FDA‑cleared products and partnerships with insulin‑pump manufacturers and digital‑health platforms. Its business model centers on selling devices, sensors, and related subscription services directly to patients, healthcare providers, and insurers.